.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Market Insights Snapshot
Oil remained the anchor at 65.23% share with a -0.98% year-over-year change and a 3.42% month-over-month lift, while Capsules expanded to 32.38% share on 19.59% YoY and 47.37% MoM growth. Pre-Roll, though only 2.40% share, spiked 5,296.03% YoY and 111.36% MoM, and the average price slipped -1.90% YoY even as total brand sales rose 7.47% YoY. With Oil’s avg price at $31.26 versus Capsules at 22.56 and Pre-Roll at 63.72, the mix shift toward Capsules and a small Pre-Roll foothold implies margin pressure offset by volume gains, and the 32.73% two-year growth alongside a rank of 5 in Oil in British Columbia suggests category depth remains essential even as emerging formats accelerate.
Capsules’ 47.37% MoM surge and 19.59% YoY rise, paired with Oil’s -0.98% YoY but positive 3.42% MoM, indicate Frank is tilting toward value-accessible formats while retaining an Oil-centric position at rank 5 in British Columbia. The 111.36% MoM and 5,296.03% YoY climb in Pre-Roll, despite only 2.40% share, coupled with a -1.90% YoY average price move and 7.47% YoY sales growth, points to a barbell strategy where Capsules drive volume and Pre-Roll tests premium elasticity, implying future share diversification if Oil’s 65.23% base can fund activation without eroding price architecture.
Competitive Landscape
Frank ranks #6 in ON Oil in September 2026, a 2-position climb from #8 year over year, while holding the same #6 position from June 2026 to September 2026; this contrasts with ufeelu moving up from #6 to #5 and Redecan holding at #2 despite a -21.2% year-over-year sales change. At the top, Mod remained #1 with a +3.2% year-over-year sales increase, and MediPharm Labs held #3 with a -12.2% decline, indicating that Frank’s tie with its peak rank (#6 in September 2026) alongside flat quarter-over-quarter position and a year-over-year rank gain suggests share stability built on relative resilience against competitors with negative sales momentum.
Notable Products
CBD Smokes Infused Pre-Roll 10-Pack (5g) posted the largest move in September 2026 with +111.4% month over month and a rank at 3, signaling a rapid uptick in trial relative to August 2026 and a credible push into inhalables. CBD 100 Oil (30ml) held rank 1 with a modest +3.4% MoM, while CBD Capsules 30-Pack (1500mg CBD) sat at rank 2 with +47.4% MoM, indicating that ingestibles still anchor the top spots even as Pre-Roll momentum accelerates. Two of the top three products are ingestibles, and the single Pre-Roll breakthrough suggests a diversification vector where inhalables complement, rather than replace, the core oil-and-capsule franchise.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
